| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | $0.00 | $0.00 |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $7.81M | $7.27M | $5.80M | $11.49M | $6.88M |
| SG&A | $6.18M | $4.78M | $5.66M | $8.76M | $4.69M |
| Operating Income | -$13.99M | -$12.05M | -$11.46M | -$27.53M | -$12.13M |
| Interest Expense | – | – | – | – | $362.00 |
| Tax Expense | – | – | – | – | -$530.61K |
| Net Income | -$13.56M | -$11.85M | -$11.12M | -$27.42M | -$11.43M |
| EPS (basic) | -10.3600 | -3.8700 | -8.4800 | -1.7000 | -0.7500 |
| EPS (diluted) | -10.3600 | -3.8700 | -8.4800 | -34.0500 | – |
| Shares (diluted) | $1.31M | $3.06M | $1.31M | $805.48K | – |